2024-09-26 08:29
Abbvie’s Parkinson’s Disease Drug Meets Main Goal in Late-stage Trial
Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. (REUTERS/Dado Ruvic) (Reuters) -AbbVie said on Thursday its drug met the main goal in a late-stage trial when tested in patients with…